Showing results (261-270 of 288) with videos related to

Sort By:
Pageof 29
AIDS Research and Human Retroviruses|October 27, 2001
HIV type 1-specific IgG2 antibodies: markers of helper T cell type 1 response and prognostic marker of long-term nonprogressionN Ngo-Giang-Huong, D Candotti, A Goubar, et al.
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|January 1, 1996
In vivo role of IL-6 on the viral load and on immunological abnormalities of HIV-infected patientsA Marfaing-Koka, J T Aubin, L Grangeot-Keros, et al.
Cephalalgia : an International Journal of Headache|December 1, 1989
Long-acting propranolol in migraine prophylaxis: results of a double-blind, placebo-controlled studyA Pradalier, G Serratrice, M Collard, et al.
Therapie|September 1, 1990
[Beta-blockers and migraine. Efficacy of time-release propranolol versus placebo]A Pradalier, G Serratrice, M Collard, et al.
Vox Sanguinis|January 1, 1988
Separation of mononuclear bone marrow cells using the Cobe 2997 blood cell separatorA Faradji, G Andreu, C Pillier-Loriette, et al.
AIDS (London, England)|June 21, 2001
HIV dynamics and T-cell immunity after three structured treatment interruptions in chronic HIV-1 infectionL Ruiz, G Carcelain, J Martínez-Picado, et al.
Clinical and Experimental Immunology|August 11, 1998
No evidence for abnormal immune activation in peripheral blood T cells in patients with hepatitis C virus (HCV) infection with or without cryoglobulinaemia. Multivirc GroupP Cacoub, L Musset, P Hausfater, et al.
AIDS (London, England)|July 9, 1999
Determinants of paradoxical CD4 cell reconstitution after protease inhibitor-containing antiretroviral regimenM Renaud, C Katlama, A Mallet, et al.
Clinical and Vaccine Immunology : CVI|June 9, 2006
Evaluation of the interlaboratory concordance in quantification of human immunodeficiency virus-specific T cells with a gamma interferon enzyme-linked immunospot assayA Samri, C Durier, A Urrutia, et al.
AIDS Research and Human Retroviruses|December 1, 1995
Safety and immunogenicity of a recombinant HIV type 1 glycoprotein 160 boosted by a V3 synthetic peptide in HIV-negative volunteersD Salmon-Céron, J L Excler, D Sicard, et al.
Pageof 29